Put Options

10 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2021

Aug 06, 2021

SELL
$6.81 - $10.93 $9,534 - $15,302
-1,400 Reduced 6.83%
19,100 $130,000
Q1 2021

May 14, 2021

BUY
$6.14 - $8.31 $28,858 - $39,057
4,700 Added 29.75%
20,500 $140,000
Q4 2020

Feb 12, 2021

BUY
$4.58 - $7.14 $72,364 - $112,812
15,800 New
15,800 $98,000
Q2 2019

Aug 20, 2019

SELL
$3.47 - $6.32 $49,621 - $90,376
-14,300 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$5.36 - $7.24 $20,368 - $27,512
-3,800 Reduced 20.99%
14,300 $77,000
Q4 2018

Feb 14, 2019

BUY
$4.8 - $11.6 $11,520 - $27,840
2,400 Added 15.29%
18,100 $94,000
Q3 2018

Nov 14, 2018

SELL
$9.05 - $10.95 $74,210 - $89,790
-8,200 Reduced 34.31%
15,700 $152,000
Q1 2018

May 15, 2018

SELL
$12.65 - $18.85 $5,060 - $7,540
-400 Reduced 1.65%
23,900 $311,000
Q4 2017

Feb 14, 2018

BUY
$17.45 - $25.6 $94,230 - $138,240
5,400 Added 28.57%
24,300 $435,000
Q3 2017

Nov 15, 2017

BUY
$18.9 - $28.2 $357,210 - $532,980
18,900
18,900 $474,000

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.